IT WAS 25 YEARS AGO that the war against cancer was officially launched by President Nixon. The ensuing investment in the study of cancer has been a major engine driving the current revolution in cell and molecular biology. Yet, the clinical rewards have been less than remarkable. This runs the
No takes yet. Share an insight, caveat, or question.
Yusuf A. Hannun (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: